Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
3.680
+0.010 (0.27%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Lexeo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
122218358---
Market Cap Growth
-39.13%-39.13%----
Enterprise Value
1171523---
Last Close Price
3.686.5813.42---
PB Ratio
1.041.863.15---
P/TBV Ratio
1.051.863.15---
Debt / Equity Ratio
0.090.090.100.19--
Asset Turnover
---0.010.02-
Quick Ratio
5.325.327.055.3918.2442.10
Current Ratio
5.525.527.215.5818.3542.15
Return on Equity (ROE)
-85.37%-85.37%-71.54%-58.84%-65.27%-
Return on Assets (ROA)
-46.11%-46.11%-36.15%-32.33%-38.07%-
Return on Capital (ROIC)
-52.48%-52.48%-40.64%-35.18%-40.81%-
Earnings Yield
-80.49%-45.18%-18.57%---
FCF Yield
-66.82%-37.51%-16.67%---
Buyback Yield / Dilution
-493.67%-493.67%-228.42%-5.00%-7.72%-
Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q